| John P Benavides, DO | |
|
2895 Lewis Ln, Paris, TX 75460-9331 | |
| (972) 203-3600 | |
| (972) 203-3601 |
| Full Name | John P Benavides |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 23 Years |
| Location | 2895 Lewis Ln, Paris, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750311726 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | L7309 (Texas) | Secondary |
| 208VP0000X | Pain Medicine - Pain Medicine | L7309 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Paragon Pain And Rehabilitation Llp | 2466616032 | 15 |
News Archive
Amsterdam Molecular Therapeutics Holding N.V., a leader in the development of gene-based therapies, today announced that it has amended and restated its licensing agreement with Amgen for gene therapy applications incorporating the GDNF (glial cell derived neurotrophic factor) gene, to which Amgen holds rights. Financial terms were not disclosed.
A new research and cooperation program has been launched, that will provide knowledge about sexual harassment in academia - and lead to research-based improvements. The initiative is led by KI jointly with KTH and Malmö University.
A new approach is needed to help reduce undernutrition and obesity at the same time, as the issues become increasingly connected due to rapid changes in countries' food systems.
The intensifying debate about health care reform in America will be addressed this week on AFGE's "Inside Government" radio show. The show will air on Friday, Aug. 14 at 10 a.m. EDT nationwide on Federal News Radio at www.federalnewsradio.com and 1500 AM in the Washington, D.C., area.
Trovagene, Inc., a developer of transrenal molecular diagnostics, announced it has granted Duke University and Duke University Health Systems a non-exclusive license to incorporate nucleophosmin protein (NPM1) into research and clinical testing services for acute myelogenous leukemia (AML).
› Verified 6 days ago
| Entity Name | Paragon Pain & Rehabilitation Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780958777 PECOS PAC ID: 2466616032 Enrollment ID: O20120611000491 |
News Archive
Amsterdam Molecular Therapeutics Holding N.V., a leader in the development of gene-based therapies, today announced that it has amended and restated its licensing agreement with Amgen for gene therapy applications incorporating the GDNF (glial cell derived neurotrophic factor) gene, to which Amgen holds rights. Financial terms were not disclosed.
A new research and cooperation program has been launched, that will provide knowledge about sexual harassment in academia - and lead to research-based improvements. The initiative is led by KI jointly with KTH and Malmö University.
A new approach is needed to help reduce undernutrition and obesity at the same time, as the issues become increasingly connected due to rapid changes in countries' food systems.
The intensifying debate about health care reform in America will be addressed this week on AFGE's "Inside Government" radio show. The show will air on Friday, Aug. 14 at 10 a.m. EDT nationwide on Federal News Radio at www.federalnewsradio.com and 1500 AM in the Washington, D.C., area.
Trovagene, Inc., a developer of transrenal molecular diagnostics, announced it has granted Duke University and Duke University Health Systems a non-exclusive license to incorporate nucleophosmin protein (NPM1) into research and clinical testing services for acute myelogenous leukemia (AML).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John P Benavides, DO Po Box 1200, Colleyville, TX 76034-1200 Ph: (972) 203-3600 | John P Benavides, DO 2895 Lewis Ln, Paris, TX 75460-9331 Ph: (972) 203-3600 |
News Archive
Amsterdam Molecular Therapeutics Holding N.V., a leader in the development of gene-based therapies, today announced that it has amended and restated its licensing agreement with Amgen for gene therapy applications incorporating the GDNF (glial cell derived neurotrophic factor) gene, to which Amgen holds rights. Financial terms were not disclosed.
A new research and cooperation program has been launched, that will provide knowledge about sexual harassment in academia - and lead to research-based improvements. The initiative is led by KI jointly with KTH and Malmö University.
A new approach is needed to help reduce undernutrition and obesity at the same time, as the issues become increasingly connected due to rapid changes in countries' food systems.
The intensifying debate about health care reform in America will be addressed this week on AFGE's "Inside Government" radio show. The show will air on Friday, Aug. 14 at 10 a.m. EDT nationwide on Federal News Radio at www.federalnewsradio.com and 1500 AM in the Washington, D.C., area.
Trovagene, Inc., a developer of transrenal molecular diagnostics, announced it has granted Duke University and Duke University Health Systems a non-exclusive license to incorporate nucleophosmin protein (NPM1) into research and clinical testing services for acute myelogenous leukemia (AML).
› Verified 6 days ago
Kimberly Smith, MSN, APRN, FNP-BC Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2895 Lewis Ln, Paris, TX 75460 Phone: 972-203-3600 |